{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:19:31Z","timestamp":1784067571747,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.arcmed.2018.04.006","type":"journal-article","created":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T22:00:45Z","timestamp":1524088845000},"page":"44-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prognostic Value of CD95, Active Caspase-3, and Bcl-2 Expression in Adult Patients with De Novo Acute Lymphoblastic Leukemia"],"prefix":"10.1016","volume":"49","author":[{"given":"Laura Arcelia","family":"Montiel-Cervantes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elba","family":"Reyes-Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Garcia-Chavez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Hernandez-Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubiraida","family":"Molina-Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam America","family":"Garcia-Ruiz Esparza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Vela-Ojeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2018.04.006_bib1","series-title":"Wintrobe's Clinical Hematology, 12 edition","first-page":"1687","article-title":"Classification and differentiation of the acute leukemias adults","author":"Head","year":"2009"},{"key":"10.1016\/j.arcmed.2018.04.006_bib2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1023\/A:1026405707823","article-title":"Apoptotic index, Fas and bcl-2 in initial and relapsed childhood acute lymphoblastic leukaemia","volume":"56","author":"Stammler","year":"1997","journal-title":"Apoptosis"},{"key":"10.1016\/j.arcmed.2018.04.006_bib3","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/cdd.2015.3","article-title":"The role of CD95 and CD95 ligand in cancer","volume":"32","author":"Peter","year":"2015","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.arcmed.2018.04.006_bib4","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cell.2007.04.031","article-title":"The CD95 receptor: apoptosis revisited","volume":"123","author":"Peter","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.arcmed.2018.04.006_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrm2308","article-title":"The BCL-2 protein family: opposing activities that mediate cell death","volume":"9","author":"Youle","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.arcmed.2018.04.006_bib6","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nrm2952","article-title":"Mitochondria and cell death: outer membrane permeabilization and beyond","volume":"11","author":"Tait","year":"2010","journal-title":"Nat Rev Mol cell Biol"},{"key":"10.1016\/j.arcmed.2018.04.006_bib7","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/35037710","article-title":"The biochemistry of apoptosis","volume":"407","author":"Hengartner","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2018.04.006_bib8","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1100\/tsw.2002.809","article-title":"Mitochondria: Regulators of Cell Death and Survival","volume":"2","author":"Granville","year":"2002","journal-title":"The Scientific World JOURNAL"},{"key":"10.1016\/j.arcmed.2018.04.006_bib9","first-page":"1783","article-title":"Proposals for the immunological classification of acute leukemias. European group for the immunological characterization of leukemias (EGIL)","volume":"9","author":"Bene","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.arcmed.2018.04.006_bib10","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3324\/haematol.2014.118588","article-title":"Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"100","author":"Daver","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.arcmed.2018.04.006_bib11","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.3390\/ijms16022942","article-title":"A Time to Kill: Targeting Apoptosis in Cancer","volume":"16","author":"Koff","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.arcmed.2018.04.006_bib12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3324\/haematol.10279","article-title":"Deregulation of apoptosis in acute myeloid leukemia","volume":"92","author":"Testa","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.arcmed.2018.04.006_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1179\/102453309X12583347113690","article-title":"An anti-apoptotic pattern correlates with multidrug resistance in acute myeloid leukemia patients: a comparative study of active caspase-3, cleaved PARPs, Bcl-2, Survivin and MDR1 gene","volume":"15","author":"Guenova","year":"2010","journal-title":"Hematology"},{"key":"10.1016\/j.arcmed.2018.04.006_bib14","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1128\/MCB.23.10.3623-3635.2003","article-title":"FAP-1 association with Fas (Apo-1) inhibits Fas expression on the cell surface","volume":"23","author":"Ivanov","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.arcmed.2018.04.006_bib15","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1074\/jbc.M509866200","article-title":"Opposite roles of FAP-1 and dynaminin the regulation of Fas (CD95) translocation to the cell surface and susceptibility to Fas ligand-mediated apoptosis","volume":"281","author":"Ivanov","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2018.04.006_bib16","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/40657","article-title":"Inhibition of death receptor signals by cellular FLIP","volume":"388","author":"Irmler","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2018.04.006_bib17","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1038\/sj.onc.1206399","article-title":"Loss of FADD protein expression results in a biased Fas-signaling pathway and correlates with the development of tumoral status in thyroid follicular cells","volume":"22","author":"Tourneur","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.arcmed.2018.04.006_bib18","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.1038\/sj.onc.1204750","article-title":"Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer","volume":"20","author":"Fulda","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.arcmed.2018.04.006_bib19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/75007","article-title":"Caspase8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN","volume":"6","author":"Teitz","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.arcmed.2018.04.006_bib20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrc776","article-title":"Death and anti-death: tumour resistance to apoptosis","volume":"2","author":"Igney","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.arcmed.2018.04.006_bib21","first-page":"4041","article-title":"Caspase-2 and caspase-3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemia","volume":"5","author":"Faderl","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.arcmed.2018.04.006_bib22","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/sj.leu.2401866","article-title":"Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax\/Bcl-2 ratio and loss of spontaneous caspase-3 processing in\u00a0vivo","volume":"14","author":"Prokop","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.arcmed.2018.04.006_bib23","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1182\/blood.V96.12.3932","article-title":"The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS","volume":"96","author":"Parker","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.arcmed.2018.04.006_bib24","first-page":"1758","article-title":"The Prognostic Impact of BCL2 Protein Expression in Acute Myelogenous Leukemia Varies with Cytogenetics1","volume":"5","author":"Kornblau","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.arcmed.2018.04.006_bib25","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1182\/blood.V84.2.595.595","article-title":"Effects of BCL-2 Antisense oligodeoxynucleotides on in\u00a0vitro proliferation and survival of normal marrow progenitors and leukemic cells","volume":"84","author":"Campos","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.arcmed.2018.04.006_bib26","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1056\/NEJMra022366","article-title":"Apoptosis and caspases in neurodegenerative diseases","volume":"348","author":"Friedlander","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2018.04.006_bib27","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1182\/blood.V87.3.1140.bloodjournal8731140","article-title":"Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia","volume":"87","author":"Coustan-Smith","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.arcmed.2018.04.006_bib28","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3109\/08880018.2015.1087611","article-title":"de novo MYC and BCL2 double-hitB-CellPrecursor acute lymphoblastic leukemia (BCP-ALL) in pediatric and young adult patients associated with poor prognosis","volume":"32","author":"Liu","year":"2015","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.arcmed.2018.04.006_bib29","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1365-2141.1998.00933.x","article-title":"A role for tumor necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic s\u00edndrome","volume":"103","author":"Gersuk","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.arcmed.2018.04.006_bib30","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.leukres.2003.08.015","article-title":"Prognostic significance of Fas (CD95) and TRAIL receptors (DR4\/DR5) expression in acute myelogenous leukemia","volume":"18","author":"Min","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.arcmed.2018.04.006_bib31","first-page":"371","article-title":"The Expression and Prognostic Impact of CD95 Death Receptor and CD20, CD34 and CD44 Differentiation Markers in Pediatric Acute Lymphoblastic Leukemia","volume":"24","author":"Kamazani","year":"2014","journal-title":"Iran J Pediatr"},{"key":"10.1016\/j.arcmed.2018.04.006_bib32","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1182\/blood.V96.12.3922","article-title":"Evaluation of Apaf-1 and procaspases-2, -3, -7, -8 and -9 as potential prognostic markers in acute leukemia","volume":"96","author":"Svingen","year":"2000","journal-title":"Blood"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S018844091830105X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S018844091830105X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:46:02Z","timestamp":1759261562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S018844091830105X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S018844091830105X"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2018.04.006","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Value of CD95, Active Caspase-3, and Bcl-2 Expression in Adult Patients with De Novo Acute Lymphoblastic Leukemia","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2018.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 IMSS. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}